PARATHYROID GLAND ENLARGEMENT

This adverse event was reported 143 times

These drugs are most commonly taken by patients reporting PARATHYROID GLAND ENLARGEMENT:

# Drug Count
0 CETIRIZINE HYDROCHLORIDE 25
1 CETIRIZINE 24
2 LORAZEPAM 24
3 ALBUTEROL SULFATE 23
4 CITALOPRAM 23
5 CITALOPRAM HYDROBROMIDE 23
6 ITRACONAZOLE 23
7 MEPOLIZUMAB 23
8 PREDNISONE 23
9 RABEPRAZOLE 23
See all common drugs associated with PARATHYROID GLAND ENLARGEMENT

PARATHYROID GLAND ENLARGEMENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM IODIDE I 123 4 0.0043
1 SODIUM IODIDE I 131 4 0.0042
2 ETELCALCETIDE 8 0.0028
3 SODIUM MONOFLUOROPHOSPHATE 1 0.0027
4 ITRACONAZOLE 23 0.0019
5 PAMIDRONATE DISODIUM 3 0.0009
6 OMEPRAZOLE 20MG 1 0.0009
7 LITHIUM CARBONATE 15 0.0009
8 PARICALCITOL 7 0.0005
9 CETIIRIZINE 21 0.0005
See all drugs enriched for association with PARATHYROID GLAND ENLARGEMENT

PARATHYROID GLAND ENLARGEMENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 23 0.0334
1 Vitamin D2 Analog [EPC] 7 0.0010
2 Provitamin D2 Compound [EPC] 12 0.0004
3 Vitamin D Analog [EPC] 7 0.0004
4 Sulfonamide Antibacterial [EPC] 1 0.0003
5 Histamine-1 Receptor Antagonist [EPC] 21 0.0002
6 Azole Antifungal [EPC] 24 0.0002
7 Vitamin D3 Analog [EPC] 3 0.0001
8 Serotonin Reuptake Inhibitor [EPC] 12 0.0001
9 Cephalosporin Antibacterial [EPC] 1 0.0001
See all drug classes enriched for association with PARATHYROID GLAND ENLARGEMENT